Duration of spasticity improvement with radial shock wave therapy in individuals with subacute troke

Duration of spasticity improvement with radial shock wave therapy in individuals with subacute troke: A Single-Center Pilot Randomized Controlled Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs042240098

Enrollment

Registered

2024-10-04

Start date

2024-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Stroke

Interventions

Radial shock wave therapy 3000 shots, 1 time or Radial shock wave therapy 6000 shots, 1 time.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals who have given written consent to participate in the study from the individual or his/her surrogate 2. Individuals aged between 18 and 90 years. 3. Individuals with stroke hemiplegia 4. Individuals with a Modified Ashworth Scale (MAS) of 1+ or higher for the triceps muscles

Exclusion criteria

Exclusion criteria: 1. Individuals with skin damage at the treatment site. 2. Individuals with acute inflammation. 3. Individuals with thrombosis. 4. Individuals who are or may be pregnant. 5. Individuals with tumours. 6. Individuals with multiple neurological disorders. 7. Individuals taking anticoagulants. 8. Individuals with a history of orthopaedic disease in the treatment area. 9. Individuals with pain during voluntary movements in the treatment area. 10. Individuals who have been treated with botulinum toxin therapy within the last 4 months. 11. Other individuals deemed inappropriate by the attending physician, the principal investigator, the principal study investigator and the study investigators.

Design outcomes

Primary

Measure	Time frame
Group differences in the immediate post-intervention effects of MAS on the triceps femoris muscle.	—

Secondary

Measure	Time frame
1. Between-group differences in effect at 1 and 8 hours, 1, 2, 3, 5, 7 and 14 days after intervention, and baseline to within-group differences at each assessment time point for MAS of the triceps femoris muscle. 2. Between-group differences in AOC of ankle dorsiflexion, ROM, MTS of triceps, tendon reflexes and clonus score at each assessment time point, and within-group differences from baseline to each assessment time point. 3. Recruitment, enrolment, adherence and retention rates	—

Measure

Time frame

1. Between-group differences in effect at 1 and 8 hours, 1, 2, 3, 5, 7 and 14 days after intervention, and baseline to within-group differences at each assessment time point for MAS of the triceps femoris muscle. 2. Between-group differences in AOC of ankle dorsiflexion, ROM, MTS of triceps, tendon reflexes and clonus score at each assessment time point, and within-group differences from baseline to each assessment time point. 3. Recruitment, enrolment, adherence and retention rates

—

Contacts

Public ContactDaisuke Kato

Fujita Health University Hospital

d-kato@fujita-hu.ac.jp+81-562-93-2167

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026